Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | R. Wesolowski, M. Zhao, S. M.Geyer, M. B. Lustberg, E. Mrozek, R. M. Layman, E. Macrae Macrae, J. Zhang, N. Hall, K. Schregel, S. Ottman, A. Camp, J. J. Chalmers, E. Andreopoulou, M. Villalona-Calero, C. L. Shapiro, M. V. Knopp, M. R. Grever, B.Ramaswamy | ||||||||||||
Title | Phase I trial of the PARP inhibitor veliparib (V) in combination with carboplatin (C) in metastatic breast cancer (MBC). | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/132155-144 | ||||||||||||
Abstract Text | J Clin Oncol. 2014;32(suppl):abstr 1074 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|